Liquidia Corporation (LQDA)
NASDAQ
Market Cap
$941.03M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
43 of 809
Rank in Industry
35 of 445
Largest Insider Buys in Sector
LQDA Stock Price History Chart
LQDA Stock Performance
About Liquidia Corporation
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
Insider Activity of Liquidia Corporation
Over the last 12 months, insiders at Liquidia Corporation have bought $11M and sold $1.54M worth of Liquidia Corporation stock.
On average, over the past 5 years, insiders at Liquidia Corporation have bought $8.97M and sold $7.2M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Caligan Partners LP () — $16M. Manning Paul B (director) — $10M. JEFFS ROGER (Chief Executive Officer) — $4M.
The last purchase of 1,117,318 shares for transaction amount of $8M was made by Caligan Partners LP () on 2023‑12‑14.
List of Insider Buy and Sell Transactions, Liquidia Corporation
| 2024-06-03 | Sale | Schundler Russell | General Counsel | 710 0.0009% | $14.55 | $10,331 | -7.94% | |
| 2024-06-03 | Sale | Kaseta Michael | CFO and COO | 1,094 0.0014% | $14.55 | $15,918 | -7.94% | |
| 2024-06-03 | Sale | Moomaw Scott | Chief Commercial Officer | 546 0.0007% | $14.55 | $7,944 | -7.94% | |
| 2024-06-03 | Sale | Adair Jason | Chief Business Officer | 455 0.0006% | $14.55 | $6,620 | -7.94% | |
| 2024-04-19 | Sale | Saggar Rajeev | Chief Medical Officer | 1,649 0.0022% | $13.68 | $22,558 | -3.31% | |
| 2024-04-12 | Sale | JEFFS ROGER | Chief Executive Officer | 8,360 0.0115% | $14.58 | $121,889 | -7.88% | |
| 2024-04-12 | Sale | Schundler Russell | General Counsel | 2,060 0.0028% | $14.58 | $30,035 | -7.88% | |
| 2024-04-12 | Sale | Kaseta Michael | CFO and COO | 3,136 0.0043% | $14.58 | $45,723 | -7.88% | |
| 2024-04-12 | Sale | Saggar Rajeev | Chief Medical Officer | 1,525 0.0021% | $14.58 | $22,235 | -7.88% | |
| 2024-04-12 | Sale | Moomaw Scott | Chief Commercial Officer | 1,585 0.0022% | $14.58 | $23,109 | -7.88% | |
| 2024-04-12 | Sale | Adair Jason | Chief Business Officer | 1,189 0.0016% | $14.58 | $17,336 | -7.88% | |
| 2024-03-18 | Sale | JEFFS ROGER | Chief Executive Officer | 28,583 0.0382% | $15.82 | $452,183 | -14.75% | |
| 2024-03-18 | Sale | Schundler Russell | General Counsel | 8,653 0.0116% | $15.82 | $136,890 | -14.75% | |
| 2024-03-18 | Sale | Kaseta Michael | CFO and COO | 12,166 0.0163% | $15.82 | $192,466 | -14.75% | |
| 2024-03-18 | Sale | Saggar Rajeev | Chief Medical Officer | 7,530 0.0101% | $15.82 | $119,125 | -14.75% | |
| 2024-03-18 | Sale | Moomaw Scott | Chief Commercial Officer | 6,108 0.0082% | $15.82 | $96,629 | -14.75% | |
| 2024-03-18 | Sale | Adair Jason | Chief Business Officer | 4,657 0.0062% | $15.81 | $73,649 | -14.75% | |
| 2024-02-29 | Sale | Moomaw Scott | Chief Commercial Officer | 546 0.0007% | $14.17 | $7,737 | -3.92% | |
| 2024-02-29 | Sale | Adair Jason | Chief Business Officer | 455 0.0006% | $14.17 | $6,447 | -3.92% | |
| 2023-12-18 | Sale | Saggar Rajeev | Chief Medical Officer | 14,887 0.0216% | $7.42 | $110,462 | +78.37% |
Insider Historical Profitability
17.92%
| Caligan Partners LP | 11280945 14.8801% | $12.32 | 1 | 0 | ||
| JEFFS ROGER | Chief Executive Officer | 826985 0.8453% | $12.32 | 5 | 2 | +34.86% |
| Manning Paul B | director | 279330 0.3685% | $12.32 | 3 | 0 | +16.39% |
| Schundler Russell | General Counsel | 487661 0.291% | $12.32 | 2 | 3 | +38.84% |
| Lippe Robert A | Chief Operations Officer | 193788 0.2556% | $12.32 | 2 | 4 | +47.2% |
| Saggar Rajeev | Chief Medical Officer | 211672 0.2165% | $12.32 | 0 | 4 | |
| Moomaw Scott | Chief Commercial Officer | 153210 0.1408% | $12.32 | 1 | 8 | +17.85% |
| Adair Jason | Chief Business Officer | 112465 0.0725% | $12.32 | 0 | 8 | |
| Kaseta Michael | Chief Financial Officer | 316295 0.0394% | $12.32 | 2 | 3 | +33.43% |
| JOHNSON DAVID EDWARD | 10643627 14.0395% | $12.32 | 4 | 0 | +22.96% | |
| Canaan VIII LP | 10 percent owner | 2917169 3.8479% | $12.32 | 2 | 0 | +22.07% |
| Eshelman Ventures, LLC | 10 percent owner | 2601210 3.4311% | $12.32 | 7 | 23 | <0.0001% |
| Bloch Stephen M | director | 2563303 3.3811% | $12.32 | 1 | 0 | +38.27% |
| BARRIS PETER J | 10 percent owner | 2484870 3.2777% | $12.32 | 1 | 0 | +38.27% |
| BASKETT FOREST | 10 percent owner | 2484870 3.2777% | $12.32 | 1 | 0 | +38.27% |
| BARRETT M JAMES | 10 percent owner | 2484870 3.2777% | $12.32 | 1 | 0 | +38.27% |
| SANDELL SCOTT D | 10 percent owner | 2484870 3.2777% | $12.32 | 1 | 0 | +38.27% |
| KERINS PATRICK J | 10 percent owner | 2484870 3.2777% | $12.32 | 1 | 0 | +38.27% |
| New Enterprise Associates 12, Limited Partnership | 10 percent owner | 2484870 3.2777% | $12.32 | 1 | 0 | +38.27% |
| GLAXOSMITHKLINE PLC | Former 10% holder | 624422 0.8236% | $12.32 | 1 | 0 | +38.27% |
| Alexandria Venture Investments, LLC | 10 percent owner | 396172 0.5226% | $12.32 | 1 | 0 | +38.27% |
| GORDON KEVIN K | President and CFO | 162265 0.214% | $12.32 | 0 | 2 | |
| Albury Timothy | SVP, Chief Accounting Officer | 38963 0.0514% | $12.32 | 0 | 3 | |
| Kirsch Arthur S | director | 32000 0.0422% | $12.32 | 4 | 0 | <0.0001% |
| Maynor Benjamin | SVP, Research and Development | 4168 0.0055% | $12.32 | 0 | 1 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Caligan Partners LP | $152.82M | 13.57 | 10.36M | 0% | +$0 | 40.4 | |
| Patient Square Capital Lp | $105.94M | 9.4 | 7.18M | New | +$105.94M | 45.11 | |
| BlackRock | $55.28M | 4.91 | 3.75M | +6.18% | +$3.22M | <0.01 | |
| The Vanguard Group | $42.59M | 3.78 | 2.89M | +1.52% | +$639,441.99 | <0.01 | |
| Kynam Capital Management Lp | $33.16M | 2.94 | 2.25M | -16.68% | -$6.64M | 0.42 | |
| Farallon Capital | $30.31M | 2.69 | 2.06M | New | +$30.31M | 0.21 | |
| State Street | $18.09M | 1.61 | 1.23M | +27.84% | +$3.94M | <0.01 | |
| Geode Capital Management | $16.67M | 1.48 | 1.13M | +8.37% | +$1.29M | <0.01 | |
| Morgan Stanley | $10.11M | 0.9 | 685,439 | -31.89% | -$4.73M | <0.01 | |
| Boothbay Fund Management LLC | $8.24M | 0.73 | 558,658 | 0% | +$0 | 0.28 | |
| Bank of America | $7.18M | 0.64 | 486,788 | +81.04% | +$3.21M | <0.01 | |
| Invesco | $6.78M | 0.6 | 459,402 | +1,047.82% | +$6.19M | <0.01 | |
| Northern Trust | $6.58M | 0.58 | 446,084 | +7.05% | +$433,458.25 | <0.01 | |
| Voloridge Investment Management, LLC | $6.23M | 0.55 | 422,499 | New | +$6.23M | 0.01 | |
| Eversept Partners LP | $5.84M | 0.52 | 396,187 | -42.49% | -$4.32M | 0.44 | |
| Opaleye Management Inc | $5.83M | 0.52 | 395,000 | -11.24% | -$737,500.00 | 0.92 | |
| HARBERT FUND ADVISORS, INC. | $5M | 0.44 | 339,158 | 0% | +$0 | 3.5 | |
| Whitefort Capital Management Lp | $4.98M | 0.44 | 337,607 | +45.8% | +$1.56M | 3.25 | |
| Jane Street Capital | $4.53M | 0.4 | 306,942 | +892.83% | +$4.07M | 0.01 | |
| Two Sigma | $4.32M | 0.38 | 292,855 | -16.64% | -$862,284.95 | 0.01 | |
| Two Sigma Advisers LP | $4.03M | 0.36 | 273,400 | -8.81% | -$389,400.00 | 0.01 | |
| Goldman Sachs | $3.9M | 0.35 | 264,461 | -38.83% | -$2.48M | <0.01 | |
| Eam Investors | $3.37M | 0.3 | 228,514 | New | +$3.37M | 0.53 | |
| Cubist Systematic Strategies | $2.76M | 0.25 | 187,176 | -31.13% | -$1.25M | 0.03 | |
| Walleye Capital | $2.69M | 0.24 | 182,078 | -42.96% | -$2.02M | 0.01 | |
| BNY Mellon | $2.59M | 0.23 | 175,885 | +2.02% | +$51,374.39 | <0.0001 | |
| Federated Hermes | $2.38M | 0.21 | 161,617 | New | +$2.38M | 0.01 | |
| Susquehanna International Group | $2.38M | 0.21 | 161,421 | -66.47% | -$4.72M | <0.01 | |
| Mitsubishi UFJ Kokusai Asset Management | $2.29M | 0.2 | 155,475 | -7.05% | -$173,946.73 | <0.01 | |
| Nuveen | $2.27M | 0.2 | 153,914 | 0% | +$0 | <0.01 | |
| Wellington Management Company | $2.24M | 0.2 | 151,965 | +115.44% | +$1.2M | <0.0001 | |
| Oberweis Asset Management Inc | $2.21M | 0.2 | 150,000 | New | +$2.21M | 0.16 | |
| Tang Capital Management, LLC | $2.21M | 0.2 | 150,000 | New | +$2.21M | 0.01 | |
| Charles Schwab | $1.96M | 0.17 | 133,044 | +0.97% | +$18,880.00 | <0.0001 | |
| Millennium Management LLC | $1.77M | 0.16 | 119,780 | -78.13% | -$6.31M | <0.01 | |
| Healthcare Of Ontario Pension Plan Trust Fund | $1.76M | 0.16 | 119,000 | New | +$1.76M | 0.01 | |
| Sigma Planning Corp | $1.56M | 0.14 | 105,890 | +167.16% | +$977,261.56 | 0.05 | |
| Walleye Trading LLC | $1.44M | 0.13 | 97,661 | -49.13% | -$1.39M | 0.02 | |
| SkyView Investment Advisors | $1.38M | 0.12 | 93,253 | -16.42% | -$270,095.87 | 0.27 | |
| Swiss National Bank | $1.32M | 0.12 | 89,800 | New | +$1.32M | <0.01 | |
| Barclays | $1.31M | 0.12 | 89,124 | -13.49% | -$204,890.47 | <0.01 | |
| UBS | $1.21M | 0.11 | 82,317 | +46.37% | +$384,635.83 | <0.0001 | |
| Credit Suisse | $1.19M | 0.11 | 80,817 | +130.91% | +$675,800.89 | <0.01 | |
| Group One Trading | $1.15M | 0.1 | 77,703 | +1,025.64% | +$1.04M | 0.03 | |
| Qube Research & Technologies | $1.12M | 0.1 | 75,978 | New | +$1.12M | <0.01 | |
| RhumbLine Advisers | $1.05M | 0.09 | 71,293 | +1.37% | +$14,189.41 | <0.01 | |
| Legal & General | $1.01M | 0.09 | 68,554 | +1,283.53% | +$938,085.71 | <0.0001 | |
| Russell Investments Group Ltd | $1.01M | 0.09 | 68,204 | -61.93% | -$1.64M | <0.01 | |
| Diametric Capital Lp | $1M | 0.09 | 67,912 | -69.44% | -$2.28M | 0.41 | |
| Canada Pension Plan Investment Board | $982,350.00 | 0.09 | 66,600 | New | +$982,350.00 | <0.01 |